[33, 34, 35, 36] Mechanism: Typically pre-renal, occurring in the setting of volume depletion from GI losses (nausea, vomiting, diarrhea, reduced oral intake) More frequently seen at higher, obesity-level doses Although generally reno-protective long term, post-marketing data describe acute rises in creatinine following days to weeks of significant GI symptoms Risk factors: Underlying chronic kidney disease Concomitant use of ACE inhibitors, ARBs, diuretics, or SGLT2 inhibitors ED Management: IV fluids Hold GLP-1 and contributing medications Usually reversible with supportive care Future Directions GLP-1 receptor agonists are rapidly evolving beyond their original indications in diabetes and obesity
Matrixyl Powder is an anti-aging cosmetic ingredient primarily composed of Palmitoyl Pentapeptide-4
Addressing a challenge of this magnitude requires exactly what we are seeing today: continuous innovation and strong, wide-reaching distribution partnerships
Typically, these medications are considered for individuals with a BMI of 30 or higher or those with a BMI of 27 or above when obesity-related conditions such as diabetes or hypertension are present
It helps fight free radicals, supports immunity, and regulates melanin production
